Tani Muu a Ta Materia Na Mama Na Mama Na Mtoto

Tani Muu a Ta Materia Na Mama Na Mama Na Mtoto

TANI MUU ATA MATERIAUS009834545B2 NA MAMA NA MAMA NA MTOTO (12 ) United States Patent ( 10 ) Patent No. : US 9 , 834 ,545 B2 Chen et al. ( 45 ) Date of Patent: Dec. 5 , 2017 ( 54 ) MODULATORS OF CHEMOKINE ( 58 ) Field of Classification Search RECEPTORS None See application file for complete search history. ( 71) Applicant : CHEMOCENTRYX , INC . , Mountain View , CA (US ) ( 56 ) References Cited (72 ) Inventors : Xi Chen , E . Palo Alto , CA (US ); Dean U . S . PATENT DOCUMENTS R . Dragoli , Los Altos, CA ( US ) ; Junfa 6 , 166 ,050 A 12 /2000 Lombardo et al. Fan , Palo Alto , CA (US ); Jaroslaw 2003 /0204085 A1 10 / 2003 Taveras et al. Kalisiak , Mountain View , CA (US ) ; 2004 / 0097547 AL 5 / 2004 Taveras et al . Antoni Krasinski, Sunnyvale , CA 2004 /0106794 Al 6 / 2004 Taveras et al. (US ) ; Manmohan Reddy Leleti, San 2004 /0147559 Al 7 / 2004 Taveras et al. 2004 /0209946 Al 10 / 2004 Yin et al . Jose , CA (US ) ; Venkat Mali, 2008 / 0261917 A1 10 / 2008 Willems et al . Cupertino , CA (US ) ; Jeffrey 2009 / 0306079 Al 12 / 2009 Taveras et al. McMahon , San Francisco , CA (US ) ; 2010 / 0029670 A1 2 /2010 Baettig et al . Rajinder Singh , Belmont, CA (US ) ; 2010 /0267712 Al 10 / 2010 Heemskerk et al . 2011 / 0086842 Al 4 / 2011 Stadtmueller et al. Hiroko Tanaka , Mountain View , CA 2011 / 0213029 Al 9 / 2011 Taveras et al. (US ) ; Ju Yang , Palo Alto , CA (US ) ; 2013 / 0231393 A1 9 / 2013 Aubert Chao Yu , Sunnyvale , CA (US ) ; Penglie 2014 /0296254 Al 10 / 2014 Musicki et al . Zhang , Foster City , CA (US ) 2014 / 0309208 A 10 / 2014 Musicki et al . 2015 /0087675 Al 3 /2015 Musicki et al . (73 ) Assignee : CHEMOCENTRYX , INC ., Mountain 2017 /0144996 Al 5 /2017 Chen et al . View , CA (US ) FOREIGN PATENT DOCUMENTS ( * ) Notice: Subject to any disclaimer, the term of this WO 01/ 64208 AL 9 / 2001 patent is extended or adjusted under 35 wo 01/ 92202 Al 12 / 2001 U . S . C . 154 (b ) by 0 days . WO 02 /057230 AL 7 / 2002 WO 02 / 067919 AL 9 / 2002 WO 02 / 076926 AL 10 / 2002 ( 21 ) Appl. No .: 15 / 353, 889 WO 02 / 083624 Al 10 / 2002 WO 03 /080053 AL 10 / 2003 ( 22 ) Filed : Nov . 17 , 2016 WO 2004 /011418 AL 2 /2004 wo 2005 /075447 AL 8 / 2005 (65 ) Prior Publication Data Wo 2006 /021544 AL 3 /2006 US 2017 /0144997 A1 May 25, 2017 ( Continued ) OTHER PUBLICATIONS Related U . S . Application Data Aki, Cynthia et al. , “ Diaminocyclobutenediones as potent and orally (60 ) Provisional application No . 62/ 257 , 389, filed on Nov. available CXCR2 receptor antagonists : SAR in the phenolic amide 19 , 2015 , provisional application No . 62/ 277 ,711 , region , " Bioorganic & Medicinal Chemistry Letters (available filed on Jan . 12 , 2016 . online May 18 , 2009 ) ; 19 :4446 - 4449 . (Continued ) (51 ) Int. Cl. C07D 405 / 14 ( 2006 . 01 ) Primary Examiner — Brian J Davis A61K 31 / 506 ( 2006 .01 ) ( 74 ) Attorney , Agent, or Firm — Mintz Levin Cohn Ferris A61K 31 /4155 ( 2006 .01 ) Glovsky and Popeo PC A61K 31 /4439 ( 2006 .01 ) A61K 31 / 454 ( 2006 .01 ) (57 ) ABSTRACT A61K 31 /341 ( 2006 .01 ) Compounds are provided as chemokine inhibitors having A61K 31 / 4035 ( 2006 .01 ) the structure : A61K 45 / 06 ( 2006 . 01 ) C07D 209 /46 (2006 .01 ) C07D 307 / 52 ( 2006 . 01 ) C07D 405 / 12 ( 2006 .01 ) RSa R56 A61K 31/ 4725 ( 2006 .01 ) (52 ) U . S . CI. 7 CPC .. .. .. .. C07D 405 / 14 (2013 .01 ) ; A61K 31 /341 N Jo ( 2013 .01 ) ; A61K 31/ 4035 ( 2013 .01 ) ; A61K ROS 31/ 4155 (2013 . 01 ) ; A61K 31 /4439 ( 2013 .01 ) ; A61K 31/ 454 (2013 . 01 ) ; A61K 31/ 4725 ROA ( 2013 .01 ) ; A61K 31/ 506 ( 2013 .01 ) ; A61K 45 / 06 ( 2013 .01 ) ; C07D 209 / 46 ( 2013 . 01 ) ; C07D 307 / 52 (2013 . 01 ) ; CO7D 405 / 12 ( 2013 .01 ) 33 Claims, 38 Drawing Sheets US 9 ,834 ,545 B2 Page 2 (56 ) References Cited Gunda, Shravan Kumar et al. , “ Structural investigations of CXCR2 receptor antagonists by COMFA , COMSIA and flexible docking FOREIGN PATENT DOCUMENTS studies , ” Acta Pharm ( Jul. 17 , 2012 ) ; 62 : 287 - 304 . Lai, Gaifa et al. , “ Synthesis and structure -activity relationships of wo 2008 /005570 AL 1 /2008 new disubstiuted phenyl -containing 3 , 4 -diamino - 3 - cyclobutene WO 2008 / 109178 A1 9 / 2008 WO 2008 / 109179 Al 9 / 2008 1 , 2 - diones as CXCR2 receptor antagonists , Bioorganic & wo 2008 / 148790 Al 12 / 2008 Medicinal Chemistry Letters (available online Feb . 10 , 2008 ) ; WO 2009 /005801 A1 1 / 2009 18: 1864 - 1868 . WO 2009 /005802 A1 1 / 2009 Liu , Shilan et al. , “ Design , synthesis , and evaluation of novel WO 2009 /012375 A2 1 / 2009 3 -amino - 4 -hydrazine -cyclobut - 3 -ene - 1 , 2 -diones as potent and WO 2009 /073683 A2 6 / 2009 WO 2009 / 156421 Al 12 / 2009 selective CXCR2 chemokine receptor antagonists, ” Bioorganic & WO 2010 / 0045303 A2 4 / 2010 Medicinal Chemistry Letters (available online Aug . 7 , 2009 ) ; WO 2010 /063802 Al 6 / 2010 19 : 5741 -5745 . WO 2010 /091543 A1 8 / 2010 WO 2010 / 131145 Al 11 / 2010 McCleland , Brent W . et al. , “ Comparison of N , N -diarylsquaramides WO 2010 / 131147 Al 11 / 2010 and N , N -diarylureas as antagonists of the CXCR2 chemokine WO 2012 /001076 A1 1 / 2012 receptor ,” Bioorganic & Medicinal Chemistry Letters (2007 ; avail W0 2012 /080456 A1 6 / 2012 WO 2012 /080457 A1 6 / 2012 able online Dec . 23 , 2006 ) ; 17 : 1713 - 1717 . WO 2013 /030803 Al 3 / 2013 Merritt , J . Robert et al . , “ Synthesis and structure -activity relation WO 2013 /061002 A1 5 / 2013 ships of 3 , 4 -diaminocyclobut - 3 -ene - 1 , 2 -dione CXCR2 wo 2013 /061004 A1 5 / 2013 antagonists ,” Bioorganic & Medicinal Chemistry Letters ( available WO 2013 / 061005 A1 5 / 2013 WO 2013 / 174947 AL 11 / 2013 online May 11 , 2006 ) ; 16 : 4107 -4110 . WO 2016 / 079049 Al 5 / 2016 Wijtmans, Maikel et al. , “ Therapeutic targeting of chemokine receptors by small molecules, " Drug Discovery Today : Technolo OTHER PUBLICATIONS gies (2012 ; http : // dx .doi . org / 10 . 1016 / j .ddtec .2012 .03 .004 ) ; 9 ( 4 ) : e229 -e236 . Asadollahi, Tahereh et al. , “ QSAR Models for CXCR2 Receptor Yu , Younong et al. , “ Synthesis and structure -activity relationships of Antagonists Based on the Genetic Algorithm for Data Preprocessing heteroaryl substituted - 3 , 4 - diamino - 3 - cyclobut- 3 - ene- 1 , 2 -dione Prior to Application of the PLS Linear Regression Method and CXCR2/ CXCR1 receptor antagonists , ” Bioorganic & Medicinal Design of the New Compounds Using In Silico Virtual Screening , " Molecules (Feb . 25 , 2011 ) ; 16 : 1928 - 1955 . Chemistry Letters ( available online Jan . 11, 2008 ); 18 : 1318 - 1322. Biju , Purakkattle et al. , “ 3 , 4 -Diamino - 2 , 5 - thiadiazole - 1 -oxides as Zhang , Shuang et al. , " Comparative Analysis of Pharmacophore potent CXCR2 / CXCR1 antagonists ,” Bioorganic & Medicinal Features and Quantitative Structure - Activity Relationships for Chemistry Letters ( 2008; available online Oct. 30 , 2007) ; 18 : 228 CD38 Covalent and Non -covalent Inhibitors , " Chemical Biology & 231 . Biju , Purakkattle et al ., “ Fluoroalkyl a side chain containing Drug Design (Dec . 2015 ; first published Jul. 14 , 2015 ) ; 86 ( 6 ) : 1411 3 , 4 - diamino - cyclobutenediones as potent and orally bioavailable 1424 . CXCR2 -CXCR1 dual antagonists , " Bioorganic & Medicinal Zhou , Yi et al. , “ Design , Synthesis and Biological Evaluation of Chemistry Letters (available online Jan . 15 , 2009 ) ; 19 : 1431 - 1433 . Noncovalent Inhibitors of Human CD38 NADase ,” ChemMedChem Biju , Purakkattle et al . , “ 3 , 4 - Diamino - 1 , 2 , 5 - thiadizole as potent and selective CXCR2 antagonists , ” Bioorganic & Medicinal Chemistry ( Feb . 6 , 2012 ) ; 7 ( 2 ) :223 -228 . Letters ( available online Jan . 15 , 2009 ) ; 19 : 1434 - 1437 . International Search Report and Written Opinion corresponding to Busch - Petersen , Jakob et al. , “ Phenol -containing antagonists of the PCT Application No . PCT/ US2016 /062417 dated Jan . 12 , 2017 , 12 CXCR2 receptor, ” Expert Opin . Ther. Patents ( published online pages May 26 , 2008 ) ; 18 ( 6 ) :629 -637 . International Search Report and Written Opinion corresponding to Chao , Jianhua et al. , “ C ( 4 ) -alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and PCT Application No. PCT/ US2016 /062427 dated Feb . 21 , 2017 ; 9 CXCR1 receptor antagonists ,” Bioorganic & Medicinal Chemistry pages . Letters ( available online Apr. 10 , 2007 ) ; 17: 3778 - 3783 . Barbosa , Maria Leticia de Castro et al ., “ Therapeutic approaches for Dwyer, Michael P . et al . , “ Discovery of 2 -Hydrozy - N , N - dimethyl tumor necrosis factor inhibition ,” Brazilian Journal of Pharmaceuti 3 - 12 - [ [ ( R ) - 1 - ( 5 -methylfuran - 2 - yl ) propyl) amino ] - 3 , 4 - dioxo cyclobut - 1 - enylamino )benzamide (SCH 527123 ) : A Potent, Orally cal Sciences ( Jul. / Sep . 2011; accepted for pub May 25, 2011 ) ; Bioavailable CXCR2/ CXCR1 Receptor Antagonist ,” J . Med . Chem . 47 : 427 -446 . ( Aug. 9 , 2006 ) ; 49 ( 26 ) : 7603 - 7606 . Nieuwenhuis , S . A . M . et al ., “ Structure of the Y , Tyrosine Radical Ebsworth , Karen et al ., " Chemokine Receptor Inhibition as a Novel in Photosystem II. Determination of the Orientation of the Phenoxyl Therapeutic Approach for Psoriasis ," Poster No . 521 Ring by Enantioselective Deuteration of the Methylene Group , " J . ChemoCentryx , Inc. , Mountain View , CA (May 12 , 2016 ) ; 2 pages. Am . Chem . Soc . ( Jan . 16 , 1998 ) ; 120: 829- 830 . U . S . Patent Dec . 5 , 2017 Sheet 1 of 38 US 9 ,834 , 545 B2 FIGURE 1A CCR6 IC50 CXCR2 IC50 O . 1 . 000 +to +uffin + ++ + ToCOHCOH 0 0 1 . 001 + + + * * * 1 .002 Nto + + + + + + -???

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    153 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us